Cardax, Inc. CDXI OTC

Other OTC • Healthcare • Biotechnology • US • USD

SharesGrow Score

27/100

0/4 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Cardax, Inc. (CDXI) .

本页证实的标准:

VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分： 25/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score

27/100

SG Score

View full scorecard →

—

价值

N/A

No coverage

—

未來

N/A

No coverage

✗

过去

0/100

→ Income

✗

健康

0/100

Debt-to-Equity & liquidity

→ Health

护城河

50/100

→ Income

成长

58/100

→ Income

—

收入

N/A

No coverage

估值概览 — CDXI

估值倍数

P/E (TTM)0.0

前瞻 P/EN/A

PEG 比率N/A

前瞻 PEGN/A

P/B 比率0.00

P/S 比率0.00

EV/EBITDA0.0

每股数据

EPS (TTM)$0.00

每股账面价值$0.00

每股营收$0.00

每股自由现金流$0.00

收益率与内在价值

盈利收益率N/A

股息收益率0.00%

EPS：实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year	EPS（稀释）	营收	净利润	净利润率
2013	$-0.28	$75.35K	$-65.16K	-86.5%
2014	$-56.44	$0.00	$-16.99M	-
2015	$-12.73	$0.00	$-4.26M	-
2016	$-4.68	$35.26K	$-1.78M	-5059%
2017	$-3.97	$610.32K	$-1.99M	-325.3%
2018	$-6.32	$1.51M	$-4.02M	-266.4%
2019	$-8.40	$710.95K	$-5.72M	-804.1%
2020	$-9.82	$538.95K	$-7.31M	-1356.8%
2021	$0.00	$0.00	$0.00	-
2022	$0.00	$0.00	$0.00	-